Cargando…
In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction
The spike (S) protein of SARS-CoV-2 is a molecular target of great interest for developing drug therapies against COVID-19 because S is responsible for the interaction of the virus with the host cell receptor. Currently, there is no outpatient safety treatment for COVID-19 disease. Furthermore, we c...
Autores principales: | García-Aguilar, Alejandra, Campi-Caballero, Rebeca, Visoso-Carvajal, Giovani, García-Sánchez, José Rubén, Correa-Basurto, José, García-Machorro, Jazmín, Espinosa-Raya, Judith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671224/ https://www.ncbi.nlm.nih.gov/pubmed/38003581 http://dx.doi.org/10.3390/ijms242216392 |
Ejemplares similares
-
Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
por: Ramírez-Salinas, Gema Lizbeth, et al.
Publicado: (2020) -
The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for Coronavirus
por: García-Machorro, Jazmín, et al.
Publicado: (2022) -
In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking
por: Vázquez-Mendoza, Luis Heriberto, et al.
Publicado: (2022) -
In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19
por: Ramírez Salinas, Gema Lizbeth, et al.
Publicado: (2023) -
Effect of Long-Term Intake of Nutritive and Non-Nutritive Sweeteners on Metabolic Health and Cognition in Adult Male Rats
por: Morales-Ríos, Emmanuel Iván, et al.
Publicado: (2022)